|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-03
|
$551,500
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes
|
4R01CA167824-05
|
$494,158
|
LIPKIN, STEVEN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
3U10CA180833-02S1
|
$100,000
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-03
|
$1,649,280
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-03
|
$9,808
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
6U10CA180847-04
|
$410,211
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of the Fes Tyrosine Kinase as an Inhibitor Target in Multiple Myeloma
|
5R21CA185702-02
|
$200,970
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of FOXM1 as a new therapeutic target in high-risk myeloma
|
1R21CA187388-01A1
|
$199,013
|
JANZ, SIEGFRIED
|
UNIVERSITY OF IOWA
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-02
|
$394,823
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
1R33CA196470-01A1
|
$394,518
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-03
|
$645,976
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-02S1
|
$50,000
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-03
|
$1,192,600
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
2P30CA134274-09
|
$2,259,773
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S1
|
$124,964
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S2
|
$200,219
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S3
|
$629,550
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S1
|
$60,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S2
|
$125,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S3
|
$246,015
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S4
|
$96,787
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S5
|
$199,999
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
4P30CA177558-04
|
$2,107,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
UM LAPs- U10 Grant
|
5U10CA180801-03
|
$682,727
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-03
|
$626,991
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Ubiquitin signaling for protein degradation
|
ZIA BC 011490
|
$882,801
|
Walters, Kylie
|
CCR (NCI)
|
|
Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression
|
5R01CA196831-02
|
$363,713
|
JELINEK, DIANE
|
MAYO CLINIC ROCHESTER
|
|
Treatment of multiple myeloma using oncolytic myxoma virus
|
1R01CA194090-01A1
|
$341,981
|
BARTEE, ERIC
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Transplant Models
|
ZIA BC 010957
|
$891,954
|
Gress, Ronald
|
CCR (NCI)
|
|
Translation of Novel Therapeutic Targets in Multiple Myeloma
|
4R01CA167511-04
|
$431,907
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$896,475
|
Larson, Daniel
|
CCR (NCI)
|
|
Toward identification of a family of novel NF-kB inducers
|
1R21CA194868-01A1
|
$195,054
|
MIYAMOTO, SHIGEKI
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
|
1R01CA207237-01
|
$395,166
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-02
|
$2,373,000
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The thrombospondin1-TGF-beta axis in multiple myeloma
|
5R01CA175012-03
|
$598,327
|
MURPHY-ULLRICH, JOANNE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
|
1R01CA195732-01A1
|
$343,125
|
LICHT, JONATHAN
|
UNIVERSITY OF FLORIDA
|
|
The Role of MMP13 in Multiple Myeloma Bone Disease
|
5R01CA175313-03
|
$331,098
|
LENTZSCH, SUZANNE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of Cereblon Pathways in Myeloma
|
5R01CA183968-03
|
$446,267
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|